UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in ADPT — Adaptive Biotechnologies Corp
CIK 861177
NEW YORK, NY
Position in ADPT
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$3,088,629
-$203,620 QoQ
Shares Held
222,524
+9.8% QoQ
Ownership
0.139%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 39.13735147669465.ToString("F0")%
Shared 0.ToString("F0")%
None 60.86264852330535.ToString("F0")%
Common Shares in ADPT Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,972,110,878 across 32 Diagnostics & Research names. ADPT ranks #22 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
2,449,697 | $1,204,099,562 | |
| 2 | DHR |
Danaher Corp /De/
|
5,225,861 | $990,823,242 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
871,789 | $489,849,516 | |
| 4 | MTD |
Mettler Toledo International Inc/
|
241,360 | $304,403,227 | |
| 5 | A |
Agilent Technologies, Inc.
|
2,646,458 | $301,643,277 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
1,499,267 | $255,684,990 | |
| 7 | LH |
Labcorp Holdings Inc.
|
900,202 | $240,182,890 | |
| 8 | WAT |
Waters Corp /De/
|
794,589 | $236,628,599 |
All Filings in ADPT
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,088,629 | 222,524 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $3,292,249 | 202,725 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $2,163,737 | 144,635 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $3,109,301 | 266,893 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,376,302 | 185,236 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $710,963 | 118,593 | Shares | Other | 2025-02-14 | |
| 2024-03-31 | $654,648 | 203,941 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $839,329 | 171,292 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $933,539 | 171,292 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $824,772 | 122,917 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,085,355 | 122,917 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $857,098 | 112,186 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $781,268 | 109,729 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $860,773 | 106,400 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $2,382,401 | 171,643 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $4,359,343 | 155,358 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $5,125,689 | 150,800 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $6,063,865 | 148,406 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $11,237,408 | 279,121 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $16,423,768 | 277,757 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $11,938,224 | 245,491 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $11,355,365 | 234,712 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $1,776,419 | 63,946 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||